DNMT3A c.715G>A ;(p.V239M)

Variant ID: 2-25471046-C-T

NM_022552.4(DNMT3A):c.715G>A;(p.V239M)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting.

Bmc Medical Genomics
Wünsch, Christian C; Banck, Henrik H; Müller-Tidow, Carsten C; Dugas, Martin M
Publication Date: 2020-02-04

Variant appearance in text: DNMT3A: 715G>A; V239M
PubMed Link: 32019565
Variant Present in the following documents:
  • 12920_2020_668_MOESM6_ESM.xls, sheet 1
  • 12920_2020_668_MOESM5_ESM.xls, sheet 1
View BVdb publication page



Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report.

Drug Design, Development And Therapy
Mao, Shiyu S; Zhang, Junfeng J; Guo, Yadong Y; Zhang, Ziwei Z; Wu, Yuan Y; Zhang, Wentao W; Wang, Longsheng L; Geng, Jiang J; Yan, Yang Y; Yao, Xudong X
Publication Date: 2019

Variant appearance in text: DNMT3A: 715G>A; Val239Ile
PubMed Link: 30666091
Variant Present in the following documents:
  • Main text
View BVdb publication page